Examples of using Afinitor in English and their translations into Polish
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Financial
-
Official/political
-
Programming
-
Computer
Severe hepatic impairment(Child-Pugh C)- Afinitor is only recommended if the desired benefit outweighs the risk.
Days(average elimination time for most commonly used moderate inhibitors) before the Afinitor dose is returned to the dose used prior to initiation of the co-administration.
The CHMP decided that Afinitor was shown to slow down disease progression in patients with advanced neuroendocrine tumours of pancreatic origin,
You should take Afinitor at the same time every day,
Afinitor is only recommended for use in patients with severe hepatic impairment(Child-Pugh C) if the potential
Afinitor must not be used in people who are hypersensitive(allergic)
For the different dose regimens Afinitor is available as 2.5 mg, 5 mg
If you are taking other medicines at the same time as Afinitor, your doctor may need to change the dose of Afinitor
If you have liver problems, your doctor may start you on a lower dose of Afinitor 2.5, 5
after study unblinding, 172 of the 203 patients(84.7%) initially randomised to placebo crossed over to open-label Afinitor.
the growth of blood vessels, Afinitor prevents the division of tumour cells
Afinitor is used to treat adult patients with:
The European Medicines Agency has waived the obligation to submit the results of studies with Afinitor in all subsets of the paediatric population in neuroendocrine tumours of pancreatic origin, thoracic neuroendocrine tumours
Afinitor is indicated for the treatment of hormone receptor-positive, HER2/neu negative advanced breast cancer,
Afinitor is used in breast cancer that is‘hormone receptor-positive'(when the cancer cells have oestrogen receptors on their surface)
It may be necessary to treat your infection before starting Afinitor. if you have previously had hepatitis B, because this may
The company that makes Afinitor will provide the results of a main study comparing treatment with Afinitor alone, treatment with Afinitor and exemestane in combination,
an individual benefit-risk assessment should be performed prior to the start of Afinitor therapy.
multicentre, phase III study of Afinitor plus best supportive care(BSC)
Do not stop taking Afinitor unless your doctor tells you to.